Navigation Links
Two Blades Foundation licenses genome engineering technology to KWS
Date:7/9/2012

EVANSTON, Ill., July 9, 2012 /PRNewswire-iReach/ -- Two Blades Foundation (2Blades) has completed a non-exclusive license agreement with KWS SAAT AG (KWS) for access to 2Blades' Transcription Activator Like (TAL) effector code technology for genome engineering in certain crops. 

The TAL code technology is a new method for making highly specific changes in genomes based on novel sequence-specific DNA-binding proteins. TAL effector proteins can be designed quickly and easily to recognize virtually any DNA sequence of interest, enabling the targeting of specific locations in a genome for precise gene replacement and modulation of gene function.  2Blades holds exclusive rights for commercial uses of the technology in plants.  Since its discovery in 2009, the efficacy of TAL effector-based DNA targeting has been established rapidly in a wide range of plant and non-plant systems.  The use of the TAL code technology in plants will enhance the efficiency and precision of the crop improvement process.

"We're pleased to complete a license with KWS for access to the TAL code technology.  It enables tools that will support their mission of delivering better seed," said 2Blades Chief Operating Officer Diana Horvath.  "KWS joins a growing list of licensees who will implement the technology in their development programs and confer a grant-back of rights to improvements that will aid 2Blades' mission of delivering benefits for subsistence farming in developing countries."  The financial terms of the agreement were not disclosed.

The TAL Code technology was discovered by Ulla Bonas, Jens Boch, Thomas Lahaye, and Sebastian Schornack at Martin-Luther University in Halle, Germany, and was named 2011 Method of the Year by the journal Nature Methods (9:1 doi:10.1038/nmeth.1852<
'/>"/>

SOURCE Two Blades Foundation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. A Genetic Approach For Crohns And Colitis Disease Is Financed By The Jeffrey Epstein VI Foundation
2. July is not just about BBQ's; the Arthritis National Research Foundation honors Juvenile Arthritis Awareness Month
3. BIRD - Israel-US Binational Industrial R&D Foundation to Invest $7.15 Million in Eight New Projects
4. Physicians Answer Questions About Food Biotechnology in IFIC Foundation Videos
5. Foundation Venture Capital Group Makes Eighth Start-Up Investment
6. Beyond Batten Disease Foundation and American Brain Foundation Launch First Clinical Research Fellowship to Treat and Cure Juvenile Batten Disease
7. Immune Deficiency Foundation Urges FDA To Exempt Immunoglobulin From Biosimilars Pathway
8. Systems Alliance Launches Redesigned Website for The Living Legacy Foundation of Maryland
9. Foundation for Health Improvement and Technology (FHIT) Launched to Beat Cardiovascular Disease
10. Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant
11. NeuroPhage Receives Michael J. Fox Foundation Funding for Parkinsons Disease Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 22, 2015   GenoSpace , a precision medicine ... to enable the broad use of genomic, imaging and other ... appointment of Michelle Munson , CEO of Aspera, an ... Logo - http://photos.prnewswire.com/prnh/20150122/170713 "We ...
(Date:12/24/2014)... Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval application ... the use of Medtronic,s SynchroMed ® II implantable ... use with United Therapeutics, Remodulin ® (treprostinil) Injection ...
(Date:12/24/2014)... 24, 2014   BioLife Solutions , Inc. (NASDAQ: ... clinical grade hypothermic storage and cryopreservation freeze ... cells and tissues  ("BioLife" or the "Company"), today announced that ... May 4, 2015 (the "Annual Meeting"). Because the ...
(Date:12/24/2014)... December 23, 2014 Earlier this year in ... director of the Adult Stem Cell Technology Center, LLC ( ... appreciated unique property of adult tissue stem cells. His ... Past, Important for the Future,” embodied the essence of his ...
Breaking Biology Technology:GenoSpace Expands Board with Appointment of Michelle Munson 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
... expansion, interactive healthcare marketing agency continues to ... grow top strategic talent ... Cadient Group, the,premier independent interactive marketing agency serving the ... "We,re grateful for each of these senior executives, contributions ...
... Pharmion Corporation,(Nasdaq: PHRM ) today reported financial results ... the year, net sales totaled $267.3 million,compared to net ... (azacitidine for injection) totaled $165.3 million for 2007,compared to ... Vidaza totaled,$131.4 million in 2007, compared to $130.6 million ...
... 19 Onyx,Pharmaceuticals, Inc. (Nasdaq: ONXX ) today ... provide an update on Nexavar(R),(sorafenib) tablets, as well as ... on Tuesday, February 19, 2008, at 10:00 a.m.,Eastern Time ... and year ended December 31, 2007 will be released ...
Cached Biology Technology:Cadient Group Announces Recent Executive Promotions 2Pharmion Corporation Announces 2007 Operating Results 2Pharmion Corporation Announces 2007 Operating Results 3Pharmion Corporation Announces 2007 Operating Results 4Pharmion Corporation Announces 2007 Operating Results 5Pharmion Corporation Announces 2007 Operating Results 6Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar and Report Full Year 2007 Financial Results 2
(Date:12/17/2014)... 2014  HITLAB SM announced today its completion of ... adherence to current U.S. Food and Drug Administration (FDA) ... device and smart phone application trials utilizing the highest ... "HITLAB is determined to improve global healthcare access, quality, ...
(Date:12/17/2014)... Dec. 16, 2014 Research and Markets ( ... "Global Chemical Sensor Market 2015-2019" report to their ... One major trend upcoming in this market is ... Chemical sensors help in recording of patient data for ...
(Date:12/15/2014)... Dec. 12, 2014 Research and Markets ( ... "Global Facial Recognition Market 2015-2019" report to their ... Facial recognition is a technology used for the ... facial feature of a person such as nose, jaw ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... have usually quite strong memories of past events like an ... not clear how the brain keeps track of the temporal ... wine before or after Mary left the party? , ... at the University of Lübeck have confirmed the widely held ...
... in the human vagina have been definitively identified in ... of the journal Immunity, published by Cell Press. The ... that will prevent HIV-1 transmission. , "The majority ... HIV infection following sexual contact," explain study authors Dr. ...
... impressive result of a study carried out by a group ... the Mario Negri Institute in Milan, Italy in cooperation with ... The study appears in the April 18th issue of the ... Science, PLoS ONE. , Stroke is the first cause of ...
Cached Biology News:Researchers discover new details about HIV-1 entry and infection 2
... Instrument System is ideal for developing ... Beadlyte reagents. The Luminex 100 Instrument ... software version 1.7, the XY platform ... offers $2000 in free Beadlyte products ...
Peptide-affinity Purified Polyclonal Antibody to ICEBERG Peptide with sequence EEDPQLASKMGLH, from C Terminus of the protein sequence according to NP_067546...
A431 cells Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
Madin-Darby bovine kidney (MDBK) cells Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
Biology Products: